Xiaopei Cui

1.6k total citations
43 papers, 1.2k citations indexed

About

Xiaopei Cui is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xiaopei Cui has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Xiaopei Cui's work include Pulmonary Hypertension Research and Treatments (6 papers), Cancer-related molecular mechanisms research (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). Xiaopei Cui is often cited by papers focused on Pulmonary Hypertension Research and Treatments (6 papers), Cancer-related molecular mechanisms research (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). Xiaopei Cui collaborates with scholars based in China, United States and Taiwan. Xiaopei Cui's co-authors include Zhen Chen, Shu Chien, I‐Chen Peng, Yi‐Shuan Li, Haiqing Gao, Hongyang Du, Hui Yang, Deyue Yu, Hao Cheng and Xuanrui Zeng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The FASEB Journal.

In The Last Decade

Xiaopei Cui

38 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xiaopei Cui 595 207 195 156 108 43 1.2k
Baolin Liu 556 0.9× 156 0.8× 119 0.6× 63 0.4× 199 1.8× 53 1.3k
Mi‐Young Jeong 538 0.9× 202 1.0× 86 0.4× 85 0.5× 164 1.5× 35 1.1k
Bon-Hong Min 452 0.8× 143 0.7× 114 0.6× 73 0.5× 169 1.6× 31 1.2k
Subhrojit Sen 431 0.7× 210 1.0× 136 0.7× 54 0.3× 109 1.0× 20 1.1k
Joe Eun Son 447 0.8× 412 2.0× 154 0.8× 82 0.5× 241 2.2× 35 1.2k
Yueh-Min Lin 649 1.1× 151 0.7× 184 0.9× 68 0.4× 144 1.3× 62 1.4k
Eun Sil Kang 550 0.9× 175 0.8× 127 0.7× 49 0.3× 137 1.3× 45 1.0k
Bingxian Xie 735 1.2× 412 2.0× 110 0.6× 100 0.6× 213 2.0× 45 1.4k
Xue Dong 509 0.9× 115 0.6× 140 0.7× 62 0.4× 122 1.1× 47 994
Daniel Schachner 457 0.8× 114 0.6× 93 0.5× 78 0.5× 42 0.4× 26 870

Countries citing papers authored by Xiaopei Cui

Since Specialization
Citations

This map shows the geographic impact of Xiaopei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopei Cui more than expected).

Fields of papers citing papers by Xiaopei Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaopei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopei Cui. The network helps show where Xiaopei Cui may publish in the future.

Co-authorship network of co-authors of Xiaopei Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaopei Cui. A scholar is included among the top collaborators of Xiaopei Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaopei Cui. Xiaopei Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoyun, Wen Cheng, Jianli Wang, et al.. (2025). Repressing cytokine storm-like response in macrophages by targeting the eIF2α-integrated stress response pathway. International Immunopharmacology. 147. 113965–113965.
2.
3.
Zhang, Yu, et al.. (2024). Optimal Combination of Right Ventricular Functional Parameters Using Echocardiography in Pulmonary Arterial Hypertension. ESC Heart Failure. 11(5). 2694–2706. 6 indexed citations
4.
Liu, Tengfei, Jing Zhang, Jianli Wang, et al.. (2024). Molecular basis of CX-5461-induced DNA damage response in primary vascular smooth muscle cells. Heliyon. 10(17). e37227–e37227. 2 indexed citations
5.
Zhang, Yang, et al.. (2024). Quadricuspid pulmonary valve with pulmonary hypertension: a case report. European Heart Journal - Case Reports. 8(11). ytae408–ytae408.
6.
Zhang, Hongyu, Chun Guang Li, Haiqing Gao, et al.. (2024). Identification of a distinct cluster of GDF15high macrophages induced by in vitro differentiation exhibiting anti-inflammatory activities. Frontiers in Immunology. 15. 1309739–1309739. 4 indexed citations
7.
Cui, Xiaopei, et al.. (2022). Selexipag-based triple combination therapy improves prognosis in Chinese pulmonary arterial hypertension patients. Frontiers in Cardiovascular Medicine. 9. 991586–991586. 5 indexed citations
8.
Cai, Qian, Jiang Zhu, Xiaopei Cui, et al.. (2022). S100A9 promotes inflammatory response in diabetic nonalcoholic fatty liver disease. Biochemical and Biophysical Research Communications. 618. 127–132. 12 indexed citations
9.
Li, Haijun, Liwei Cui, Shuang Dou, et al.. (2021). Ginsenoside Rb3 Alleviates CSE-Induced TROP2 Upregulation Through p38 MAPK and NF-κB Pathways in Basal Cells. American Journal of Respiratory Cell and Molecular Biology. 64(6). 747–759. 14 indexed citations
10.
Chen‐Izu, Ye, Tengfei Liu, Wenjing Zhang, et al.. (2021). Anti-fibrotic effects of p53 activation induced by RNA polymerase I inhibitor in primary cardiac fibroblasts. European Journal of Pharmacology. 907. 174303–174303. 8 indexed citations
11.
Cui, Xiaopei, Hong Xin, Lei Zhang, et al.. (2021). A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities. Frontiers in Immunology. 12. 778978–778978. 37 indexed citations
12.
Liu, Zhiwei, et al.. (2020). Long noncoding RNAs: Important participants and potential therapeutic targets for myocardial ischaemia reperfusion injury. Clinical and Experimental Pharmacology and Physiology. 47(11). 1783–1790. 7 indexed citations
13.
Cui, Xiaopei, et al.. (2016). PGC‐1α Mediated Peripheral Nerve Protection of Tongxinluo in STZ‐Induced Diabetic Rats. Evidence-based Complementary and Alternative Medicine. 2016(1). 1287909–1287909. 3 indexed citations
14.
Du, Hongyang, Xuanrui Zeng, Xiaopei Cui, et al.. (2015). Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9. Journal of Biotechnology. 217. 90–97. 167 indexed citations
15.
Cui, Xiaopei, et al.. (2013). Segmental Hair Analysis after a Single Dose of Zolpidem: Comparison with a Previous Study. Journal of Analytical Toxicology. 37(6). 369–375. 28 indexed citations
16.
Chen, Zhen, Tsung‐Ching Lai, Yi‐Hua Jan, et al.. (2013). Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis. Journal of Clinical Investigation. 123(3). 1057–1067. 154 indexed citations
17.
Liu, Xiangju, Jie Qiu, Shaohua Zhao, et al.. (2012). Grape seed proanthocyanidin extract alleviates ouabain-induced vascular remodeling through regulation of endothelial function. Molecular Medicine Reports. 6(5). 949–954. 25 indexed citations
18.
Chen, Zhen, et al.. (2010). Shear stress, SIRT1, and vascular homeostasis. Proceedings of the National Academy of Sciences. 107(22). 10268–10273. 234 indexed citations
19.
Lü, Mei, Ling Xu, Baoying Li, et al.. (2010). Protective Effects of Grape Seed Proanthocyanidin Extracts on Cerebral Cortex of Streptozotocin-Induced Diabetic Rats through Modulating AGEs/RAGE/NF-κB Pathway. Journal of Nutritional Science and Vitaminology. 56(2). 87–97. 34 indexed citations
20.
Cui, Xiaopei, Baoying Li, Haiqing Gao, et al.. (2008). Effects of Grape Seed Proanthocyanidin Extracts on Peripheral Nerves in Streptozocin-Induced Diabetic Rats. Journal of Nutritional Science and Vitaminology. 54(4). 321–328. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Baolin Liu Breakdown of academic impact, for papers by Mi‐Young Jeong Breakdown of academic impact, for papers by Bon-Hong Min Breakdown of academic impact, for papers by Subhrojit Sen Breakdown of academic impact, for papers by Joe Eun Son Breakdown of academic impact, for papers by Yueh-Min Lin Breakdown of academic impact, for papers by Eun Sil Kang Breakdown of academic impact, for papers by Bingxian Xie Breakdown of academic impact, for papers by Xue Dong Breakdown of academic impact, for papers by Daniel Schachner
Rankless by CCL
2026